STAT1 activation in association with JAK2 exon 12 mutations

• Anna L. Godfrey,
• Edwin Chen,
• Charles E. Massie,
• Yvonne Silber,
• Francesca Pagano,
• Beatriz Bellosillo,
• Paola Guglielmelli,
• Claire N. Harrison,
• John T. Reilly,
• Frank Stegelmann,
• Fontanet Bijou,
• Eric Lippert,
• Jean-Michel Boiron,
• Konstanze Döhner,
• Alessandro M. Vannucchi,
• Carlos Besses,
• Anthony R. Green

Affiliations

Anna L. Godfrey

Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, Addenbrooke’s Hospital, UK;Department of Haematology, University of Cambridge, Cambridge, UK

Edwin Chen

Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, University of Cambridge, Cambridge, UK

Charles E. Massie

Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, University of Cambridge, Cambridge, UK

Yvonne Silber

Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, University of Cambridge, Cambridge, UK

Francesca Pagano

Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, University of Cambridge, Cambridge, UK

Beatriz Bellosillo

Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain

Paola Guglielmelli

Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliera Universitaria Careggi, Florence, Italy

Claire N. Harrison

Department of Haematology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

John T. Reilly

Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK

Frank Stegelmann

University Hospital of Ulm, Department of Internal Medicine III, Germany

Fontanet Bijou

Institut Bergonie, Department of Hematology, Bordeaux, France

Eric Lippert

Laboratoire d’Hematologie, CHU de Bordeaux and Laboratorie Hematopoiese Leucemique et Cibles Thérapeutiques, INSERM U 1035, Universite Bordeaux Segalen, Bordeaux, France

Jean-Michel Boiron

University of Bordeaux, Etablissement Français du Sang, France

Konstanze Döhner

University Hospital of Ulm, Department of Internal Medicine III, Germany

Alessandro M. Vannucchi

Department of Experimental and Clinical Medicine, University of Florence and Azienda Ospedaliera Universitaria Careggi, Florence, Italy

Carlos Besses

Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain

Anthony R. Green

Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK;Department of Haematology, Addenbrooke’s Hospital, UK;Department of Haematology, University of Cambridge, Cambridge, UK